Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration (Kinesia-D)

Great Lakes NeuroTechnologies

Status: Completed

Conditions: Parkinson's Disease

Study type: Observational

Funder types: Other; Industry; NIH

Identifiers

NCT02125825

KinesiaDPhaseIIYear1

9R44AG044293 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.

Enrollment: 14 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of idiopathic Parkinson's disease
• Clinical history of levodopa-induced dyskinesia
• 21 Years of age or older
• Stage 2 - 4 OFF-medication on the Hoehn and Yahr scale

Exclusion criteria

• Dementia (determined by a neuropsychological assessment)
• Severe tremor unaffected by levodopa

Trial design

14 participants in 1 patient group

Parkinson's disease on levodopa

Description:

Individuals with Parkinson's disease who are taking levodopa to treat motor symptoms